A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Metastatic Gastroesophageal Junction or Gastric Cancer

Mise à jour : Il y a 4 ans
Référence :

Extrait


Critère d'inclusion

  • HER2-positive metastatic gastroesophageal junction or gastric cancer

Liens